ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
768K |
9 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
2.2K
|
768K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity Receives $10 million R&D Tax Incentive
|
|
ma420
|
4 |
2.4K |
14 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
4
|
2.4K
|
14
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix to present at Melbourne Twilight Investor Briefing
|
|
ma420
|
95 |
39K |
32 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
95
|
39K
|
32
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity Receives $10 million R&D Tax Incentive
|
|
ma420
|
4 |
2.4K |
6 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
4
|
2.4K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
537 |
206K |
22 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
537
|
206K
|
22
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
888 |
304K |
11 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
888
|
304K
|
11
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
888 |
304K |
5 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
888
|
304K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
888 |
304K |
3 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
888
|
304K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ma420
|
2.1K |
723K |
23 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2.1K
|
723K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ma420
|
2.1K |
723K |
6 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2.1K
|
723K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
636 |
227K |
6 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
636
|
227K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
537 |
206K |
45 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
537
|
206K
|
45
|
|
ASX - By Stock
|
DXB |
Re:
DXB options
|
|
ma420
|
46 |
24K |
3 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
46
|
24K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ma420
|
2.1K |
723K |
18 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
2.1K
|
723K
|
18
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
22K |
7.6M |
4 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
22K
|
7.6M
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
888 |
304K |
9 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
888
|
304K
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
22K |
7.6M |
3 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
22K
|
7.6M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ma420
|
905 |
269K |
2 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
905
|
269K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ma420
|
905 |
269K |
4 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
905
|
269K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
768K |
4 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
2.2K
|
768K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
768K |
5 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
2.2K
|
768K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Proposed issue of securities - PAA
|
|
ma420
|
15 |
3.6K |
6 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
15
|
3.6K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ma420
|
159 |
41K |
3 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
159
|
41K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Proposed issue of securities - PAA
|
|
ma420
|
15 |
3.6K |
3 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
15
|
3.6K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Proposed issue of securities - PAA
|
|
ma420
|
15 |
3.6K |
17 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
15
|
3.6K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
768K |
11 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
2.2K
|
768K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
768K |
12 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
2.2K
|
768K
|
12
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
888 |
304K |
12 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
888
|
304K
|
12
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
888 |
304K |
9 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
888
|
304K
|
9
|
|
ASX - By Stock
|
COV |
Re:
Ann: Restricted securities to be released from escrow
|
|
ma420
|
3 |
1.3K |
1 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
768K |
9 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
2.2K
|
768K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
768K |
13 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
2.2K
|
768K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
888 |
304K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
888
|
304K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
ma420
|
554 |
201K |
4 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
554
|
201K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
ma420
|
146 |
44K |
12 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
146
|
44K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
ma420
|
120 |
42K |
23 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
120
|
42K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ma420
|
159 |
41K |
12 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
41K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ma420
|
159 |
41K |
20 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
41K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
ma420
|
80 |
25K |
6 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
25K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix to present at Melbourne Twilight Investor Briefing
|
|
ma420
|
95 |
39K |
5 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
95
|
39K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
537 |
206K |
11 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
537
|
206K
|
11
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ma420
|
230 |
109K |
7 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
230
|
109K
|
7
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ma420
|
230 |
109K |
22 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
230
|
109K
|
22
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ma420
|
230 |
109K |
20 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
230
|
109K
|
20
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
537 |
206K |
2 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
537
|
206K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
537 |
206K |
2 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
537
|
206K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ma420
|
230 |
109K |
4 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
230
|
109K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ma420
|
230 |
109K |
16 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
230
|
109K
|
16
|
|
ASX - By Stock
|
DXB |
Re:
Banter and general comments
|
|
ma420
|
80 |
31K |
1 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
80
|
31K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
537 |
206K |
3 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
537
|
206K
|
3
|
|